Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Prosser, H.
Right arrow Articles by Walley, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prosser, H.
Right arrow Articles by Walley, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Family Practice Vol. 20, No. 5, 583-591
© Oxford University Press 2003

Health Services Research

New drug uptake: qualitative comparison of high and low prescribing GPs’ attitudes and approach

Helen Prosser and Tom Walley

Prescribing Research Group, Department of Pharmacology and Therapeutics, The Infirmary, 70 Pembroke Place, Liverpool L69 3GF, UK.

Correspondence to Helen Prosser; E-mail: H.Prosser{at}liverpool.ac.uk

Background. Prescribing varies considerably between GPs, and a minority of GPs account for a large proportion of new drug prescribing.

Objective. Our aim was to explore the differences in approach and attitudes towards new drug prescribing between high and low GP prescribers.

Methods. Semi-structured interviews were undertaken with 30 GPs who were either high or low prescribers of new drugs. Interview topics included reasons for prescribing new drugs; use of information sources; attitudes and approach to drug innovation; and consideration of the balance of risk and therapeutic benefit.

Results. Differences in GPs’ appraisal of new drugs enabled the development of a classification of attitudes and approaches applying to high and low prescribers. Difference in the behaviours of each group is a matter of degree of attitude or influence rather than (usually) its absence. Key dimensions in the classification are attitudes towards new drug prescribing, perception of risk and benefits, strategies adopted for risk management, information-seeking behaviour and use of the pharmaceutical industry as a significant information source.

Conclusion. Variability in GP prescribing of new drugs relates not only to levels of acquired knowledge, but also to differences in subjective and ideological beliefs.

Keywords. General practice, GP attitudes, GP behaviour, new drugs, prescribing influences.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
S. R Florentinus, R. van Hulten, M. E. Kloth, E. R Heerdink, A. F. Griens, H. G. Leufkens, P. P Groenewegen, and for the Netherlands Institute for Health Services
The Effect of Pharmacotherapy Audit Meetings on Early New Drug Prescribing by General Practitioners
Ann. Pharmacother., February 1, 2007; 41(2): 319 - 324.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
H. J. van Duijn, M. M. Kuyvenhoven, F. G. Schellevis, and T. J. M. Verheij
Determinants of prescribing of second-choice antibiotics for upper and lower respiratory tract episodes in Dutch general practice
J. Antimicrob. Chemother., August 1, 2005; 56(2): 420 - 422.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.